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Abstract
Background and Aims—Despite many studies of rectal cancer outcomes, no clear relationship
between hospital or surgeon volume and patient outcomes has emerged for rectal cancer. We aimed
to characterize the effect of hospital and surgical volume on surgery type and surgical outcomes in
rectal cancer through a systematic review of the literature.
Methods—We conducted a systematic review of studies evaluating the association between hospital
or surgeon volume and rectal cancer outcomes. We searched PubMed for relevant articles and
reviewed 23 articles. We describe each study and report outcomes in terms of the effect of hospital
or surgeon volume on the type of surgery performed, surgical complications, postoperative mortality,
survival, and recurrence.
Results—Hospitals and surgeons with higher caseloads appear to perform more sphincter-
preserving surgeries and have lower post-operative mortality rates. Hospital and surgeon volume
appear to have no effect or a small beneficial effect on the rate of leaks, complication rate, local
recurrence, overall survival, and cancer-specific survival.
Conclusions—For rectal cancer, the effects of hospital volume may be stronger for more short-
term outcomes. Beyond the immediate recovery period, the effect of hospital and surgeon volume
may be minimal. As more technically challenging operations, such as total mesorectal resection,
become more widespread it will be important to evaluate the impact of hospital and surgeon volume
on outcomes.
Introduction
Rectal cancer will affect over 41,000 people in the U.S. in 2007, the majority of whom will
undergo surgery.1-3 There have been important advances in the surgery for rectal cancer that
have favorably impacted quality of life and survival. More widespread use of low anterior
resection has obviated the need for a colostomy for most patients. Local therapy, often
accompanied by neo-adjuvant therapy has further enhanced the chances for sphincter-sparing
surgery. Mesorectal resection, although not widely practiced, has been shown to improve
survival.4 As is the case for other operations there is reason to suspect that the quality of rectal
cancer care depends on hospital and surgeon caseloads.
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Hospital and surgeon volume have been demonstrated to affect outcomes for patients with
cancers that require high-risk procedures, such as pancreatic and esophageal cancers.5 When
the risk is lower, as is the case for colorectal surgery, it may be more difficult to demonstrate
a difference with increased surgical volume because most patients survive and few have
complications. Several studies have addressed colorectal cancer surgery and found inconsistent
evidence for a volume outcome relationship.6 There may be more variation in outcomes from
rectal cancer surgery compared to colon cancer surgery because the operation is more difficult
technically and because there are likely to be greater differences in performance across
surgeons and hospitals. Despite many studies of rectal cancer outcomes, no clear relationship
between hospital or surgeon volume and patient outcomes has emerged for rectal cancer alone.
The purpose of this systematic review of the literature was to determine whether hospital and
surgeon volume influence the type of surgery performed and outcomes of surgery for rectal
cancer. A rigorous qualitative approach was optimal considering the heterogeneity of the
outcomes measures. Systematic reviews can elucidate clear patterns of results in the absence
of more quantitative data analysis. We hypothesized that hospitals and surgeons with higher
volumes, and therefore more experience, would have higher rates of sphincter-sparing surgery,
fewer local complications and better survival than lower volume hospitals.
Methods
Search strategy
We searched the MEDLINE database through April 2007 for all English-language articles
using the following search strategy:
((colorectal cancer) OR (cancer AND (rectum OR colorectal OR rectal))) AND surgery AND
(treatment outcome OR outcome* OR quality OR adverse OR treatment failure OR length of
stay OR mortality OR survival OR recurrence OR intraoperative complications OR
postoperative complications)
AND (caseload* OR workload OR ((hospital OR surgeon OR surgery) AND volume))
One authors (TS) reviewed abstracts of possibly relevant titles, and then reviewed possibly
relevant manuscripts along with the reference list of included articles or review articles for
additional relevant articles. The type of outcome was not limited in advance.
Inclusion criteria
We required that studies include results for rectal cancer patients and that all studies report
original data for which bivariate or multivariate results were reported. Studies reporting results
without showing effect sizes were included.
Exclusion criteria
We excluded articles for which results for rectal cancer could not be distinguished from larger
patient groups, such as articles where cancers of the colon and rectum were aggregated.
Exposures
The number of cases per hospital (hospital volume) or the number of cases per surgeon (surgeon
volume) had to be stated.
Measures and outcomes
Because hospital and surgeon volume may be associated with sphincter-sparing surgery, we
sought information on type of surgery. Similarly, we included data on use of radiation therapy.
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The outcomes of interest were short- and long-term surgical outcomes including complications,
length of stay, mortality, survival, and recurrence rates.
Quality assessment
Although we did not formally rate the quality of reports, we recorded and present information
on variables that may reflect the quality of reporting. The variables included study design
(retrospective or prospective), recency of data collection, data source, sample size, and
inclusion of important prognostic factors in multivariate analyses.
Analysis
We constructed an evidence table (Table) that described each study in terms of volume (hospital
volume, surgeon volume, or both), treatment type, and short- and long-term outcomes.
Statistical significance was specified at a level of α = 0.05. We included summary statistics for
significant effect sizes, if they were reported in the study. Statistical significance was reported
from each study, even if significance was for a trend rather than a reported effect size. In studies
where hospital or surgeon volume was measured categorically, the table shows the mean
number of cases per year that define high and low volumes. Comparisons between the highest
and lowest volume groups were reported. If both bivariate and multivariate results were
reported, only multivariate results were included in this review. Outcomes for which only
bivariate analyses were reported are noted in the summary table. Because neoadjuvant and
adjuvant therapies are potentially important prognostic factors, outcomes for which these
therapies were controlled are noted in the summary table.
We constructed a figure in order to provide a graphical representation of the effect of hospital
and surgeon volume on outcome. Individual studies were categorized into tertiles based on the
number of rectal cancer patients included in each study. Similar outcomes were aggregated to
simplify the results. For example, post-operative mortality and in-hospital mortality were
grouped as post-operative mortality. Cancer-specific survival, relative survival, and disease-
specific mortality were grouped as cancer-specific survival. Each finding was categorized as
a negative, neutral, or beneficial effect of volume on that outcome,
The original search yielded 526 articles, of which 41 addressed colon or rectal cancer. We
found thirteen additional articles from the reference sections of other studies or review articles.
After removing articles that did not include rectal cancer outcomes separate from colon cancer
outcomes, 22 studies remained. Eleven studies addressed the influence of hospital volume, six
studies addressed the influence of surgeon volume, and five studies addressed both.
Results
This review included 5,984,195 patients from eight North American and European countries
over the years 1979 − 2002. The definition of rectal cancer varied. In most cases rectal cancer
was defined by ICD code. In six studies rectal cancer was defined as cancers located a maximum
of 12 to 16 cm from the anal verge.
Type of surgery performed
Twelve studies reported the type of surgery performed.7-18 The operations were categorized
as either sphincter-sparing procedures (SSP), which included low anterior resection and local
excision, or abdominoperineal resections (APR), which included permanent colostomy or
ostomy. Low anterior resections yielding temporary colostomies were considered SSPs.
Of the nine studies that measured hospital volume and surgery type, five found a positive
association between higher hospital volume and higher rate of sphincter-sparing procedures.
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9-12, 16 The significant odds ratios were 0.44, 0.55, and 0.73.9, 10, 12 Significant differences
between APR rates for high and low volume hospitals were reported as 26.4% vs. 29.8% for
high and low volume, respectively, in one study, and 47% vs. 49% for high and low volume
hospitals, respectively, in another study.11, 16 Three studies showed no effect of hospital
volume on type of surgery performed.8, 15, 17 A final study showed a decreasing trend of APR
rates for lower volume hospitals, but no analyses were done on the data to establish an effect
size or statistical significance. It is counted as no effect for this review.7
Four of the six studies that measured surgeon volume found a positive relationship between
higher surgeon volume and higher rate of sphincter-sparing procedures.13-15, 19 Significant
odds ratios ranged from 0.22 to 0.70, and one study demonstrated APR rates of 38.9% for low
volume surgeons and 49.2% for high volume surgeons13-15, 19 The remaining two studies of
surgeon volume showed no effect of surgeon volume on the type of surgery performed.8, 18
A tenth study reported the effect of hospital volume and number of anterior resections,
abdominoperineal resections, and Hartmann's procedures, and while a significant trend was
found, no post-hoc analyses identified the direction of this effect.20
The ten positive associations found between volume (either hospital or surgeon) and rate of
sphincter-sparing procedures, and the lack of negative associations, suggest that higher volume
hospitals and higher volume surgeons perform more sphincter-sparing procedures.
Surgical complications
Surgical complications were measured in six studies, and the type of complications varied by
study.9, 11, 18-21 Anastomotic leak was identified as a complication in all six studies.9, 11,
18-21 Other types of complications were included in some studies, as described below.
Four studies of surgical complications investigated the influence of hospital volume. 9, 11,
20, 21 One study described multiple intraoperative complications, including iatrogenic
perforation; hemorrhage; ureteral injury; injury to spleen, bladder, or neighboring organs; and
complications associated with pneumoperitoneum.11 In the same study, general and specific
complications were measured, but not defined. This study found an association of higher
hospital volume and fewer complications on all outcomes except general complications; this
was counted as a single overall beneficial effect of higher hospital volume for this analysis.
11 Two studies showed an association between higher hospital volume and lower complication
rate. 11, 20 Both studies used bivariate analyses. The percentages of complication rates in high
vs. low hospitals that were significant for trend were 13.6% vs. 18.5% for intraoperative
complications, 29.8% vs. 34.5% for postoperative complications, 13.0% vs. 11.2% for
anastomotic leaks in one study, and 7.3% vs. 8.3% for anastomotic leaks in the other study.
11, 20 The two other studies, which used multivariate analyses, showed no effect of hospital
volume on complication, where complications included wound infection in one study 21 and
anastomotic leak in both studies 9, 21. Because these findings were mixed, it is difficult to
conclude any consistent effect. However, the better conducted studies using multivariate
analyses found no effect, suggesting that there is no effect of hospital volume on complication
rates.
One of the three studies measuring the effect of surgical volume on complication rates reported
a relationship between higher surgeon volume and lower complication rate (OR = 0.7).21 The
other two studies found no effect.18, 19
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Local recurrence rate was assessed in seven studies.12, 13, 18, 20-23 The actual definition of
local recurrence (recurrence in the pelvis) was only stated in three studies.13, 20, 22 One study
measured cancer recurrence risk in any site.12 Another study measured distant metastasis.18
Of the five studies measuring the association of hospital volume with local recurrence rate,
three studies found no effect 21-23. Two studies found that higher hospital volume was
associated with lower local recurrence risk, with an odds ratio of 0.91 in one study 12 and a
hazard ratio of 0.5 in the other.20 Any effect of hospital volume on local recurrence rate, if an
effect exists, appears small.
Four studies assessed the role of surgeon volume on local recurrence rates.13, 18, 21, 23 One
study reported no association between surgeon volume and local recurrence 21, and the other
three studies found that higher volume surgeons had lower local recurrence 13, 18, 23. The
significant hazard ratios for local recurrence were 0.42 18 and 0.56 13. In the studies showing
only percentages, the statistically significant rates of local recurrence were 11% vs. 17% for
high and low volume surgeons, respectively.23
The study that measured risk for recurrence at any site and the study that measured distant
metastasis found no effect of hospital volume.12, 18
Mortality
Thirty-day post-operative mortality was identified in eight studies.8-10, 13, 18-21, 24 Three
additional studies measured in-hospital mortality.11, 17, 25 One study measured two-year
mortality.8
For this analysis, thirty-day and in-hospital mortality are grouped together as postoperative
mortality to reflect short-term mortality after surgery. Eight studies measured the relationship
between hospital volume and postoperative mortality. Two studies found that high volume was
associated with low postoperative mortality, with odds ratios of 0.92 25 and 0.38 10. The
remaining six studies showed no effect of hospital volume.8, 9, 11, 17, 20, 21 Taken together,
the eight studies showed a positive effect for the two larger studies, suggesting that a small
protective effect on mortality may be conferred on patients at higher volume hospitals that may
only be detected in larger studies.
Six studies evaluated the effect of surgeon volume on post-operative mortality.8, 13, 18, 19,
21, 25 Four studies found no effect of surgeon volume 8, 13, 18, 21, and two studies found
that higher volume surgeons had lower mortality rates, with odds ratios of 0.87 25 and 0.58
19.
The study measuring two-year mortality found no effect of hospital volume, but found that
higher surgeon volume resulted in lower two-year mortality (24% in high volume hospitals vs.
34% in high volume hospitals).8
Survival
Fifteen studies reported survival using proportional hazards models.8-10, 12, 13, 16-18,
20-23, 26-29 The time period of survival analysis outcomes was assessed for two years in one
study 22, and at least five years in the remaining studies.
Overall survival, independent of cause of death, was measured in ten studies.8-10, 12, 16, 17,
20, 22, 23, 27 Of the ten studies of overall survival, an association between higher hospital
volume and higher overall survival was found in four studies, with odds ratios ranging from
1.09 to 1.28. 10, 17, 20, 27 The remaining six studies found no association 8, 9, 12, 16, 22,
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23. The small effect sizes and the preponderance of null results suggests no effect of hospital
volume on overall survival. For the two studies of surgeon volume, one study found a positive
relationship between higher surgeon volume and longer survival (RR = 1.35) 8, and one study
found no significant relationship 23.
Two studies calculated relative survival, comparing observed survival to expected survival of
people with similar demographic characteristics.12, 22, 28 One study measured cancer-specific
survival, with an endpoint of local recurrence or death from rectal cancer 13, while three others
measured disease-specific survival, with an endpoint of death from rectal cancer 18, 21, 29.
One study measured disease-free survival with an endpoint of local tumor recurrence, a second
primary colorectal cancer, or death from any cause. Although relative survival, cancer-specific
survival, disease-specific survival, and disease-free survival, are defined somewhat differently
in the included studies, they were evaluated as relative survival in this analysis, because they
all generally reflect survival with death from cancer as the outcome. The four studies of hospital
volume showed no effect of hospital volume on relative survival.12, 21, 22, 28
Two of the five studies of surgeon volume found a positive effect of volume and relative
survival, with hazard ratios for survival of 1.4 and 1.89. 13, 18 Three studies of surgeon volume
and relative survival showed no effect 21, 26, 29. This pattern suggests that neither hospital
nor surgeon volume influences relative survival.
Other findings
Adjuvant therapy use was reported as an outcome in only one study, which investigated the
association between surgeon volume and rates of radiation therapy utilization and found no
effect of volume on use of adjuvant therapy.15 One study measured length of stay after surgery
for rectal cancer and found that higher volume hospitals were associated with shorter lengths
of stay.11 A study investigated surgeon caseload and rates of reoperation and found no effect.
18
Possible moderators
Some study-level variables may affect the influence of hospital and surgeon volume on surgery
type and surgical outcomes. We collected data on location of study, recency of data collection
completion, size of the study, and reporting of only bivariate effects. We found no apparent
pattern between the location of the study and any of the associations found in this review. We
also found no pattern with regard to recency of data collection completion.
Across all studies, studies in the largest tertile (>6,000 patients) generally showed stronger
associations between hospital volume and various outcomes. The same pattern appeared for
studies of surgeon volume, although the studies of surgeon volume are fewer and smaller.
Bivariate analyses generally showed a more beneficial effect of both hospital and surgeon
volume than did multivariate analyses.
Discussion
Hospital volume and surgeon volume have been shown to influence patient care in some
cancers. For rectal cancer, the volume-outcomes relationship appears to be small but positive.
This systematic review of 22 published studies of rectal cancer surgery type and outcomes
found that across all studies, high hospital volume and high surgeon volume have either a
beneficial or neutral effect on patient care and outcomes.
Because the larger studies more often showed a beneficial effect of high hospital or surgeon
volume than the smaller studies, especially for short-term outcomes such as post-operative
mortality and colostomy rate, the positive effects of high hospital and surgeon volume may be
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too small to detect in all but the larger studies. The studies also may have lacked sufficient
power to demonstrate clinically important differences, particularly because many of the
outcomes we investigated were uncommon. None of the studies found a detrimental effect of
high hospital or surgeon volume. If there were truly no effect of hospital or surgeon volume,
one would expect some studies to demonstrate a detrimental effect of hospital or surgeon
volume as part of a normal variation of findings.
For hospital volume, the evidence suggests that high volume hospitals perform more sphincter-
sparing procedures and have lower post-operative mortality, even if these effects are small. It
is less clear that higher hospital volume has any effect on anastomotic leaks, complications, or
overall survival, for which findings were mixed between neutral and beneficial. Hospital
volume does not appear to influence cancer-specific survival. Most of the studies were
performed before total mesorectal excision was developed. The impact of this surgery on short
and long term outcomes is not reflected in this review.
Studies of surgeon volume demonstrate the same effects. There are fewer studies of surgeon
volume, and the studies are generally smaller than those of hospital volume, but higher surgeon
volume is always associated with either no effect or a positive effect on patient care and
outcomes.
Halm et al. proposed that hospital and surgeon volume have little effect on procedures that are
less risky.5 Rectal cancer surgery is more complicated than colon cancer surgery, where
minimal effects for hospital and surgeon volume have been found.6 However, rectal cancer
surgery is less complicated than pancreatic or esophageal cancer surgery, where dramatic
effects of hospital and surgeon volume are seen. For less technically complicated cancer
surgeries, such as those required for rectal cancer, perhaps any effect of hospital volume is
stronger for more short-term outcomes, as we found in this review. Beyond the immediate
recovery period, the effect of the success of surgery may be minimal. However, surgeries for
rectal cancer are becoming more technically complicated, and with these more complicated
procedures, such as total mesorectal excision, we may see more dramatic effects of surgeon
and hospital volume on surgical outcomes. Although total mesorectal excision may improve
outcomes, we hypothesize that the benefits may be greater when performed in higher volume
hospitals or by surgeons with larger caseloads.
This systematic review of the literature has limitations. First, because of the heterogeneous
outcomes and measures, we were unable to perform a more quantitative meta-analysis.
However, this systematic review presents a qualitative analysis that describes a general pattern
of the volume-outcomes relationship. The studies in this review include diverse definitions of
high and low hospital and surgeon volume. They also represent different parts of the world and
widely varying data sources. Data were collected over different time periods, starting from as
far back as 1979 to as recently as 1999, and surgical procedures have changed significantly
over this time period.
The quality of these studies also varied greatly. Six studies had sample sizes below 1000
patients, which may limit the power to detect small effects. Many findings arose from bivariate
analyses, not adjusting for clinical and demographic factors in the analyses. Sixteen of the
studies looked at surgeon or hospital volume alone, without investigating the interaction
between surgeons and hospitals. Only five studies controlled for clustering between surgeons
or between hospitals.
Despite the variation in study design and quality, a clear pattern of the effect of hospital and
surgeon volume on rectal cancer treatment and outcomes emerges from this systematic review.
Hospitals and surgeons with higher caseloads appear to perform more sphincter-preserving
surgeries and have lower post-operative mortality rates. Hospital and surgeon volume appear
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to have no effect or a small beneficial effect on the rate of leaks, complication rate, local
recurrence, overall survival, and cancer-specific survival. As more technically challenging
operations, such as mesorectal resection, become more widespread it will be important to
evaluate the impact of hospital and surgeon volume on outcomes.
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